As previously discussed, Fra-2 transgenic mice display a pro-fibrotic phenotype characterized by a dramatic activation of fibroblasts and macrophages, eventually promoting systemic sclerosis, lung fibrosis, vascular remodeling, and inflammation [25–27, 32, 33]. This evidence concerns the gene FOSL2 and pulmonary fibrosis.